Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Global Wholehealth Partners Corporation (GWHP : OTC)
 
 • Company Description   
Global WholeHealth Partners Corporation manufactures and markets various in vitro diagnostic test kits principally in the United States. The Company sells and develop in-vitro diagnostic products, including rapid diagnostic tests, such as the COVID-19 Test, rapid whole blood Ebola Test, whole blood Zika test, blood rapid TB test and other tests. Global WholeHealth Partners Corporation is based in San Clemente, California.

Number of Employees:

 
 • Price / Volume Information   
Yesterday's Closing Price: $0.01 Daily Weekly Monthly
20 Day Moving Average: 674,898 shares
Shares Outstanding: 110.29 (millions)
Market Capitalization: $1.32 (millions)
Beta: 4.25
52 Week High: $0.74
52 Week Low: $0.01
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -56.20% -52.19%
12 Week -81.39% -79.89%
Year To Date -82.86% -79.69%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
1402 N El Camino Real
-
San Clemente,CA 92672
USA
ph: 714-392-9752
fax: -
investors@gwhpcorp.com http://gwhpcorp.com
 
 • General Corporate Information   
Officers
Charles Strongo - Chief Executive Officer and Director
Rene Alvarez - Chief Operating Officer; President and Director
Shuijie Cui - Chief Science Officer and Director
Scott Ford - Director
Wolfgang Groeters - Director

Peer Information
Global Wholehealth Partners Corporation (BJCT)
Global Wholehealth Partners Corporation (CADMQ)
Global Wholehealth Partners Corporation (APNO)
Global Wholehealth Partners Corporation (UPDC)
Global Wholehealth Partners Corporation (IMTIQ)
Global Wholehealth Partners Corporation (CYGN)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED PRODUCTS
Sector: Medical
CUSIP: 37959N102
SIC: 2835
Fiscal Year
Fiscal Year End: June
Last Reported Quarter: 12/01/21
Next Expected EPS Date: 05/19/22
Share - Related Items
Shares Outstanding: 110.29
Most Recent Split Date: (:1)
Beta: 4.25
Market Capitalization: $1.32 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 05/19/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: -
Price/Cash Flow: -
Price / Sales: 32.92
EPS Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -50.00%
Sales Growth
vs. Year Ago Period: -99.89%
vs. Previous Quarter: -88.78%
ROE
03/31/22 - -
12/31/21 - -
09/30/21 - -
ROA
03/31/22 - -
12/31/21 - -
09/30/21 - -
Current Ratio
03/31/22 - -
12/31/21 - 0.16
09/30/21 - 1.33
Quick Ratio
03/31/22 - -
12/31/21 - 0.11
09/30/21 - 1.27
Operating Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Net Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Pre-Tax Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Book Value
03/31/22 - -
12/31/21 - -0.02
09/30/21 - 0.00
Inventory Turnover
03/31/22 - -
12/31/21 - 2.24
09/30/21 - 1.79
Debt-to-Equity
03/31/22 - -
12/31/21 - -
09/30/21 - 0.00
Debt-to-Capital
03/31/22 - -
12/31/21 - -
09/30/21 - 0.00
 

Powered by Zacks Investment Research ©